Orchid Chemicals a decent stock: Ashwani Gujral
This is a decent pharma stock to have particularly because Rakesh also tends to own it.
By 
|
| Ashwani Gujral, Chief Market Strategist, ashwanigujral.com, in a chat with ET Now talks about Orchid Chemicals.
What is the call on Orchid Chemicals?
It hit supports around 230 and now is in a buying zone. So it is likely that it will go back up to 340 in case the markets remain cheerful. This is a decent pharma stock to have particularly because Rakesh also tends to own it. So 260 is a support here and 340 could be an achievable target.
What is the call on Orchid Chemicals?
It hit supports around 230 and now is in a buying zone. So it is likely that it will go back up to 340 in case the markets remain cheerful. This is a decent pharma stock to have particularly because Rakesh also tends to own it. So 260 is a support here and 340 could be an achievable target.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
